Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
@RichardDugdale3
To summarise last nights rns-
#Eurasiamining receive offers high enough to allow due diligent access
Rosgeo JV prompted a new offeror who blew offers out the water upon seeing the value of the cornerstone mt
BOD have agreed to the offer and ended FSP in order to accept. #EUA
Amryt said the deal, which would grant it access to Mycapssa, Chiasma’s hormonal disorder drug, would create a global leader in treatments for rare diseases.
It has been approved and recommended by the boards of both companies. Amryt said yesterday that the plan would deliver annual cost synergies of approximately $50 million.
Reason for London fall in SP?
A London-listed biotechnology company specialising in rare diseases has agreed to buy an American rival.News of Amryt Pharma’s $296.7 million all-stock deal for the US-based developer Chiasma propelled shares in its target up by 38.7 per cent to $3.94.
We will start to move north soon. £10 is my target over the years.
After trading between 20p and 30p for much of 2021, it now looks as if the Eurasia Mining (LSE: EUA) share price is on the verge of breaking out. A surge in buying this week has pushed the stock above 29p. A further jump in buying could send the shares above 30p.
What can be said categorically is that this pattern of auction bidding does seem suspicious and is consistent with the hypothesis, suggested by the previous weekend's intense trolling activity, that the stock is currently being shorted.
The answer, as you may have suspected, is to provide a false signal to help drive the share price down. It would appear trivially easily to arrange for very low UT prices on a small block of shares simply by selling back to yourself or a connected party. This of course would be considered market abuse, and would be illegal. But this does not mean that it can not happen - let's inspect the data to see if there is any evidence that it may be happening.